If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAviva Regulatory News (AV.)

Share Price Information for Aviva (AV.)

Share Price is delayed by 15 minutes
Get Live Data
671.80    3.40 (0.51%)
Bid:
671.60
Ask:
671.80
Spread: 0.20 (0.03%)
Market Cap: £20.10b
AV. Live PriceLast checked at - London Stock Exchange

Intraday Aviva Share Chart

Admission to Trading

28 May 2026 14:39

RNS Number : 1087G
Aviva PLC
28 May 2026
Β 

Β 

28 May 2026

Β 

Β 

Β 

Admission to trading of Aviva plc's €575,000,000 Tier 2 Fixed to Floating Rate Notes due November 2057

Β 

Aviva plc's (the "Company") €575,000,000 Tier 2 Fixed to Floating Rate Notes due November 2057 (ISIN: XS3318828012) (the "Notes") have been admitted to the Official List of the Financial Conduct Authority (the "FCA") and to trading on the Main Market of the London Stock Exchange on 28 May 2026.

Β 

The Notes were issued by the Company under its Β£7,000,000,000 Euro Note Programme (the "Programme") updated on 11 March 2026. The Final Terms are available for viewing at http://www.rns-pdf.londonstockexchange.com/rns/1087G_3-2026-5-28.pdf.

Β 

The Final Terms should be read in conjunction with the Base Prospectus dated 11 March 2026 prepared in respect of the Programme (the "Prospectus"), as supplemented by a Supplemental Prospectus dated 15 May 2026 (the "Supplemental Prospectus"). The Prospectus (which was approved by the FCA on 11 March 2026) is available for viewing at http://www.rns-pdf.londonstockexchange.com/rns/1087G_1-2026-5-28.pdf, and the Supplemental Prospectus (which was approved by the FCA on 15 May 2026) is available for viewing at http://www.rns-pdf.londonstockexchange.com/rns/1087G_2-2026-5-28.pdf.

Β 

The Company's LEI is YF0Y5B0IB8SM0ZFG9G81.

Β 

-ends-

Β 

Β 

Enquiries:

Β 

Β Media:

Β Andrew Reid

+44 (0)7800 694 276

Β Sarah Swailes

+44 (0)7800 694 859

Β Investors and Analysts:

Β Greg Neilson

+44 (0)7800 694 564

Β 

Β 

This announcement does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities.

Β 

The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any State or other jurisdiction of the United States, and are subject to Unites States tax law requirements. Subject to certain exceptions, the securities referred to herein may not be offered, sold or delivered in the United States (as defined in Regulation S under the Securities Act) or to, or for the account or benefit of, U.S. persons (as defined in the U.S. Internal Revenue Code of 1986, as amended, and regulations thereunder). Neither the Prospectus nor the Supplementary Prospectus may be accessed from, or transmitted in or into, the United States. Accordingly, these securities may not be offered, sold or delivered in the United States.

Β 

Please note that the information contained in the Supplemental Prospectus and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Supplemental Prospectus or the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Β 

Your right to access this service is conditional upon complying with the above requirements.

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ADMEADSPADEKEFA
Date   Source Headline
6th Jul 20267:00 amRNSTransaction in Own Shares
3rd Jul 20262:26 pmRNSForm 8.3 - Prologis Inc.
3rd Jul 20267:00 amRNSTransaction in Own Shares
2nd Jul 202612:22 pmRNSForm 8.3 - DCC plc
2nd Jul 20267:00 amRNSTransaction in Own Shares
1st Jul 20265:31 pmRNSTotal Voting Rights
1st Jul 20265:30 pmRNSIssue of Shares
1st Jul 20261:55 pmRNSForm 8.3 - DCC plc
1st Jul 20267:00 amRNSStatement re Rule 19.6(c)
30th Jun 20261:44 pmRNSForm 8.3 - Prologis Inc.
29th Jun 20262:08 pmRNSForm 8.3 - Tate & Lyle plc
29th Jun 20262:05 pmRNSForm 8.3 - Segro plc
29th Jun 20262:02 pmRNSForm 8.3 - LondonMetric Property & Schroder REIT
26th Jun 20261:43 pmRNSForm 8.3 - DCC plc
26th Jun 20269:00 amRNSPost Stabilisation Notice
25th Jun 20262:16 pmRNSForm 8.3 - Segro plc
25th Jun 20262:15 pmRNSForm 8.3 - Prologis Inc.
25th Jun 20262:13 pmRNSForm 8.3 - DCC plc
24th Jun 20265:15 pmRNSHolding(s) in Company
24th Jun 20261:51 pmRNSForm 8.3 - DCC plc
24th Jun 20267:00 amRNSTransaction in Own Shares
23rd Jun 20267:00 amRNSTransaction in Own Shares
22nd Jun 20261:56 pmRNSForm 8.3 - Tate & Lyle plc
22nd Jun 20261:54 pmRNSForm 8.3 - LondonMetric Property & Schroder REIT
22nd Jun 20261:53 pmRNSForm 8.3 - DCC plc
22nd Jun 202611:00 amRNSNotice of Redemption and Listing Cancellation
22nd Jun 20267:00 amRNSTransaction in Own Shares
19th Jun 20261:46 pmRNSForm 8.3 - DCC plc
19th Jun 20267:00 amRNSTransaction in Own Shares
18th Jun 20262:08 pmRNSForm 8.3 - DCC plc
18th Jun 20267:00 amRNSTransaction in Own Shares
17th Jun 20264:45 pmRNSDirector/PDMR Shareholding
17th Jun 20261:45 pmRNSForm 8.3 - LondonMetric Property & Schroder REIT
17th Jun 20261:43 pmRNSForm 8.3 - DCC plc
17th Jun 20267:00 amRNSTransaction in Own Shares
16th Jun 20262:11 pmRNSForm 8.3 - LondonMetric Property & Schroder REIT
16th Jun 20262:08 pmRNSForm 8.3 - Intertek Group plc
16th Jun 20262:06 pmRNSForm 8.3 - DCC plc
16th Jun 202612:15 pmRNSNotice of Special Redemption Price
16th Jun 20267:00 amRNSTransaction in Own Shares
15th Jun 20261:55 pmRNSForm 8.3 - Intertek Group plc
15th Jun 20261:54 pmRNSForm 8.3 - DCC plc
15th Jun 20267:00 amRNSTransaction in Own Shares
12th Jun 20261:50 pmRNSForm 8.3 - Tate & Lyle plc
12th Jun 20261:47 pmRNSForm 8.3 - Intertek Group plc
12th Jun 20267:00 amRNSTransaction in Own Shares
11th Jun 20261:48 pmRNSForm 8.3- Tate & Lyle plc
11th Jun 20261:47 pmRNSForm 8.3 - DCC plc
11th Jun 202610:04 amRNSHolding(s) in Company
11th Jun 20269:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.